The new report by Expert Market Research titled, ‘Global Conjugate Vaccine Market Share, Report and Forecast 2024-2032’, gives an in-depth analysis of the global conjugate vaccine market, assessing the market based on its segments like types, disease indications, diseases, pathogen types, patients, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Conjugate Vaccine Market Size, Share, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2018-2032)
- Historical Market Size (2023): USD 16 Billion
- Forecast CAGR (2024-2032): 11%
- Forecast Market Size (2032): USD 40.9 Billion
The pandemic bolstered the conjugate vaccine market in the historical period as some biotechnology companies researched to develop vaccines to prevent the spread of COVID-19. For instance: in July 2021, BioFarma, a corporation of Cuba, announced Soberana 2 vaccine against COVID 19 spread. The increasing prevalence of diseases and the use of conjugate vaccines for adults worldwide are driving the market growth of the conjugate vaccines industry.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/conjugate-vaccine-market/requestsample
In addition, the rising regulatory approvals by organisations, such as the World Health Organisation and the growing awareness about the efficiency of the vaccine is also resulting in the steady growth of the market. The expanding geriatric population and their susceptibility to the diseases are providing impetus to the growth of the conjugate vaccine industry.
Conjugate Vaccine Market Definition and Major Segments
The conjugate vaccine combines weak antigens and strong antigens to enable the immune system to strongly respond to the weak antigen by producing T cells and antibodies. The doses are administered to immunise the population against diseases, like influenza, diphtheria tetanus and pertussis, and meningococcal, among others.
The conjugate vaccine industry, by type, is divided into
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
Based on disease indication, the market is segmented into:
- Pneumococcal
- Influenza
- Diphtheria Tetanus and Pertussis (DTP)
- Meningococcal
- Others
On the basis of pathogen type, the market is divided into:
- Bacterial Conjugate Vaccine
- Viral Conjugate Vaccine
- Combined Conjugate Vaccine
Based on patient, the market is segmented into:
- Adults
- Paediatrics
The regional markets for conjugate vaccine include:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/conjugate-vaccine-market
Conjugate Vaccine Market Trends
The efforts taken by governments across the world to immunise the population to reduce mortality and morbidity is leading to the incremental development of the conjugate vaccine industry. The Government of India launched Pneumococcal Conjugate Vaccine (PCV) in May 2017 to reduce infant mortality and morbidity caused by pneumococcal pneumonia in Bihar, Himachal Pradesh, Madhya Pradesh, 19 districts of Uttar Pradesh and 18 districts of Rajasthan. The initiatives of industry players in launching vaccines and getting them approved by regulatory bodies are also resulting in the expansion of the conjugal vaccine industry. For instance: in July 2021, Merck declared the approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) by the United States Food and Drug Administration against invasive pneumococcal disease in adults 18 years and older. The ongoing research activities to develop efficient vaccines is expected to augment the conjugate vaccine industry in the forecast period.
Key Market Players
The major players in the market are Serum Institute of India Pvt., Ltd., Groupe Sanofi, Pfizer Inc., Novartis AG, and Bharat Biotech Ltd., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Jhon Roy,Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
